Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00DJE
|
|||
| Former ID |
DNC013879
|
|||
| Drug Name |
N-(2,3-dihydro-1H-inden-2-yl)quinazolin-4-amine
|
|||
| Synonyms |
CHEMBL471242; N-(2,3-dihydro-1H-inden-2-yl)quinazolin-4-amine; SCHEMBL9040263
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H15N3
|
|||
| Canonical SMILES |
C1C(CC2=CC=CC=C21)NC3=NC=NC4=CC=CC=C43
|
|||
| InChI |
1S/C17H15N3/c1-2-6-13-10-14(9-12(13)5-1)20-17-15-7-3-4-8-16(15)18-11-19-17/h1-8,11,14H,9-10H2,(H,18,19,20)
|
|||
| InChIKey |
CLVFUKGYGOFREN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2190-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.